retatrutide 2 week results The next installment of the triple agonist is here with more top-line phase 3 results. TRANSCEND-T2D-1: Retatrutide in adults with obesity and type diabetes. 📉 Lowered A1C of 1.7%–2.0% across How Long Does Retatrutide Take

What is the mechanism of action of GLP-1

EVOKE and EVOKE+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimers disease

Furthermore, while chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain established risk factors for HCC, they also induce changes in lipid and glucose homeostasis

Rather than sitting on the filtering cells of the nephron, the receptor is found mainly in the smooth muscle of the renal vasculature, so much of GLP-1s renal effect is hemodynamic and hormonal rather than a direct action on kidney tubules